Bangkok Lab & Cosmetic PCL
Bangkok Lab And Cosmetic Public Company Limited manufactures and distributes pharmaceuticals and medicinal chemical products for humans and animals in Thailand, Laos, Cambodia, Hongkong, Myanmar, and internationally. The company distributes food supplements, cosmeceuticals, cosmetic, and pharmaceutical products; medicine, medical supplies, tonics, and supplements for animals; and supplementary fo… Read more
Bangkok Lab & Cosmetic PCL (BLC) - Total Assets
Latest total assets as of June 2024: ฿2.17 Billion THB
Based on the latest financial reports, Bangkok Lab & Cosmetic PCL (BLC) holds total assets worth ฿2.17 Billion THB as of June 2024.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Bangkok Lab & Cosmetic PCL - Total Assets Trend (2021–2023)
This chart illustrates how Bangkok Lab & Cosmetic PCL’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Bangkok Lab & Cosmetic PCL - Asset Composition Analysis
Current Asset Composition (December 2023)
Bangkok Lab & Cosmetic PCL's total assets of ฿2.17 Billion consist of 77.9% current assets and 22.2% non-current assets.
| Asset Category | Amount (THB) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ฿0.00 | 4.0% |
| Accounts Receivable | ฿346.50 Million | 15.5% |
| Inventory | ฿392.83 Million | 17.5% |
| Property, Plant & Equipment | ฿0.00 | 0.0% |
| Intangible Assets | ฿0.00 | 0.0% |
| Goodwill | ฿0.00 | 0.0% |
Asset Composition Trend (2021–2023)
This chart illustrates how Bangkok Lab & Cosmetic PCL's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Bangkok Lab & Cosmetic PCL's current assets represent 77.9% of total assets in 2023, an increase from 57.9% in 2021.
- Cash Position: Cash and equivalents constituted 4.0% of total assets in 2023, up from 2.1% in 2021.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2021.
- Asset Diversification: The largest asset category is inventory at 17.5% of total assets.
Bangkok Lab & Cosmetic PCL Competitors by Total Assets
Key competitors of Bangkok Lab & Cosmetic PCL based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Lonkey Industrial Co Ltd Guangzhou
SHE:000523
|
China | CN¥3.66 Billion |
|
Taiyen Biotech Co Ltd
TW:1737
|
Taiwan | NT$8.26 Billion |
|
Tianjin Yiyi Hygiene Products Co Ltd
SHE:001206
|
China | CN¥2.20 Billion |
|
Hunan Resun Co Ltd
SHE:001218
|
China | CN¥3.08 Billion |
|
Dencare (Chongqing) Oral Care Co. Ltd. A
SHE:001328
|
China | CN¥1.90 Billion |
|
Qingdao Kingking Applied Chemistry Co Ltd
SHE:002094
|
China | CN¥3.19 Billion |
|
C&S Paper Co Ltd
SHE:002511
|
China | CN¥9.17 Billion |
|
Anhui Deli Household Glass Co Ltd
SHE:002571
|
China | CN¥3.08 Billion |
Bangkok Lab & Cosmetic PCL - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Bangkok Lab & Cosmetic PCL generates 0.63x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Solid ROA - For every $100 in assets, Bangkok Lab & Cosmetic PCL generates $6.49 in net profit.
Bangkok Lab & Cosmetic PCL - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 4.43 | 3.27 | 3.27 |
| Quick Ratio | 3.35 | 2.47 | 2.47 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | ฿1.24 Billion | ฿ 1.26 Billion | ฿ 1.26 Billion |
Bangkok Lab & Cosmetic PCL - Advanced Valuation Insights
This section examines the relationship between Bangkok Lab & Cosmetic PCL's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.49 |
| Latest Market Cap to Assets Ratio | 0.01 |
| Asset Growth Rate (YoY) | 84.7% |
| Total Assets | ฿2.24 Billion |
| Market Capitalization | $12.24 Million USD |
Valuation Analysis
Below Book Valuation: The market values Bangkok Lab & Cosmetic PCL's assets below their book value (0.01 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Bangkok Lab & Cosmetic PCL's assets grew by 84.7% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Bangkok Lab & Cosmetic PCL (2021–2023)
The table below shows the annual total assets of Bangkok Lab & Cosmetic PCL from 2021 to 2023.
| Year | Total Assets | Change |
|---|---|---|
| 2023-12-31 | ฿2.24 Billion | +84.74% |
| 2022-12-31 | ฿1.21 Billion | +12.41% |
| 2021-12-31 | ฿1.08 Billion | -- |